← Leaderboards
Angela Dispenzieri
Mayo Clinic Coll Of Medicine, Rochester
$3,292,004
Attributed
$4,039,782
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $514.4K · FY2006–22$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,039,782 · 6
By mechanism
R01$2,735,829 · 2
P30$819,287 · 1
R21$461,723 · 1
M01$22,943 · 2
Top collaborators
- Stephen J Russell3 shared
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- Stephen J Russell$9,318,537
- Keith C Bible$4,335,431
- Donald J. Tindall$5,698,348
- Roberto B. Cattaneo$13,481,773
- Rafael Fonseca$16,992,958
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsSafetyGrantMultiple MyelomaPharmaceutical PreparationsProtocols DocumentationRefractoryMalignant NeoplasmsNeoplastic CellMeasles VirusPeripheral BloodClinical ResearchDepositionPre-ClinicalCd46 AntigenCell KillingCyclophosphamideDoseCellsImmune ResponseImageMonitorClinical ProtocolsOncolytic Viruses
Grant awards (16)
Protocol Review and Monitoring System$203,601
P30 · FY2022 · CA · contact PI
Protocol Review and Monitoring System$203,477
P30 · FY2021 · CA · contact PI
Protocol Review and Monitoring System$206,762
P30 · FY2020 · CA · contact PI
Protocol Review and Monitoring System$205,447
P30 · FY2019 · CA · contact PI
Measles Virotherapy for Multiple Myeloma$498,645
R01 · FY2014 · CA
Measles Virotherapy for Multiple Myeloma$482,471
R01 · FY2013 · CA
Measles Virotherapy for Multiple Myeloma$514,441
R01 · FY2012 · CA
Virotherapy for Relapsed Refractory Multiple Myeloma$247,872
R01 · FY2011 · CA · contact PI
Virotherapy for Relapsed Refractory Multiple Myeloma$246,204
R01 · FY2010 · CA · contact PI
Virotherapy for Relapsed Refractory Multiple Myeloma$245,693
R01 · FY2009 · CA · contact PI
Virotherapy for Relapsed Refractory Multiple Myeloma$246,400
R01 · FY2007 · CA · contact PI
Virotherapy for Relapsed Refractory Multiple Myeloma$254,103
R01 · FY2006 · CA · contact PI
Escalating Doses of Samarium With Fixed Dose Melphalan$18,076
M01 · FY2004 · RR
Flavopiridol in Patients with Relapsed /Refractory MM$4,867
M01 · FY2004 · RR
Phase II Trial of Thalidomide in Primary Amyloidosis$226,238
R21 · FY2002 · CA
Phase II Trial of Thalidomide in Primary Amyloidosis$235,485
R21 · FY2001 · CA